Results 191 to 200 of about 23,778,628 (351)

Accelerating cell culture media development using Bayesian optimization-based iterative experimental design. [PDF]

Nat Commun
Narayanan H, Hinckley JA, Barry R, Dang B, Wolffe LA, Atari A, Tseng YY, Love JC.   +7 more
europepmc   +1 more source

3058) Experimental Tests of Aluminium Sashes Especially Designed to Prevent Condensation of Water on the Surfaces(Scientific Basis of Planning Building)

, 1963
Koichi Nitsuta, Kenji Kusaka
openalex   +2 more sources

Verbal interference with visual classification: Optimal processing and experimental design [PDF]

, 1976
John H. Flowers, Beccy Blair
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

An Experimental Design to Investigate Item Parameter Drift. [PDF]

Appl Psychol Meas
Baldwin P, Grabovsky I, Swygert KA, Fogle T, Reid P, Clauser BE.   +5 more
europepmc   +1 more source

DESIGN OF AN EXPERIMENTAL BOWABLE FUEL ELEMENT FOR THE SRE

, 1964
C.L. Peckinpaugh
openalex   +2 more sources

Ready-signal effects as a function of experimental design in simple reaction time [PDF]

, 1973
K Henriksen, J.D. Holmes
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Evaluation of an experimental short interview form designed to collect fertility data: The case of Peru [PDF]

, 1973
Albert M. Marckwardt
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source